FDA documents say patients with drug-coated stents have a small, but significant risk of blood clots. The data was released just days before an FDA panel was scheduled to consider the health risks of such stents. In a related development, results from a study indicate anti-clotting drugs such as Plavix can significantly reduce the risk for patients with drug-coated stents.

Related Summaries